Equities
AT&T Stock Tumbles to 52-Week Low of $19.26
The telecom giant's shares hit a new yearly trough, down 17.4% over the past year, even as the company posts trailing-twelve-month profitability and offers a 6.91% dividend yield.
CRH Stock Drops to 52-Week Low Amid Acquisition Uncertainty
CRH plc’s shares fell to a five-year low of $83.65 amid a 31% year-to-date decline, as analysts adjust expectations ahead of a $150-per-share cash acquisition of Arcosa Inc.
Verbio Reports €194m EBITDA Surge in FY 2025/26 on Regulatory Shift
Verbio SE's EBITDA surged to €193.9 million in FY 2025/26, driven by regulatory shifts and increased production volumes. The company's net debt decreased to €91.5 million, and equity ratio improved to 59.7%.
Lowe’s stock dips to $188.22 amid analyst downgrades and housing market uncertainty
Lowe’s Companies Inc. hit a 52-week low of $188.22, reflecting a 26.26% year-over-year decline, as analysts revised price targets amid concerns over housing demand and strategic expansion needs.
JPMorgan Asset Management Crosses 5% Stake in Everplay Group
JPMorgan Asset Management Holdings Inc. disclosed a 5.16% voting-rights position in Everplay Group plc after filing a regulatory notification on Tuesday under UK disclosure rules.
Equifax shares dip to 52‑week low of $150.63
Equifax stock fell to $150.63, its lowest level in a year, as analysts trimmed price targets despite a beat on Q2 earnings and a steady dividend record.
NiSource stock dips to $39.01, 52-week low amid earnings and regulatory focus
NiSource Inc. hit a $39.01 low, just 1% above its 52-week floor, as earnings missed estimates and analysts trimmed targets amid regulatory scrutiny and growth challenges.
Duke Energy Stock Falls to 52‑Week Low of $113.88 Amid Sector Pressures
Duke Energy’s shares slipped to a 52‑week low of $113.88, down 6.75% over the past year, as the utility posted second‑quarter adjusted earnings of $1.43 per share and revenue of $7.59 billion while facing heightened regulatory review in Indiana.
Clover Health Appoints Former Senator Torricelli, Dr. Miller to Board
Clover Health Investments added former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its board, filling two vacancies and bringing the total to nine directors.
CoTec extends convertible debenture offering deadline to Oct. 15
CoTec Holdings extends its $20 million non-brokered debenture offering; Kings Chapel commits up to $5 million at final closing.
TELUS Cuts Dividend by 55% as It Shifts Focus to Profitability
The telecom giant plans to redirect CAD 2.7 billion in capital toward AI infrastructure and operational efficiency by 2028, while targeting a leverage ratio of 3.0x or lower.
WildBrain reports mixed Q4 2026 results amid restructuring
Revenue fell 29% year-over-year, but adjusted EBITDA guidance points to a turnaround by fiscal 2029.
Prestige Consumer Healthcare Reaffirms Growth Plan Amid Supply Constraints
Revenue declined 4.3% YoY in fiscal 2026, but free cash flow targets remain robust, with guidance for 10% CAGR through 2029.
JPMorgan Chase Stock Rises to Near Record as Banking Giant Posts Strong Revenue
JPMorgan shares close near $366.50 record as CEO Dimon cites solid fundamentals; Q2 revenue of $57.35 billion supports full-year guidance despite rate cut sensitivity.
McCormick declares $0.48 quarterly dividend, pays 102nd consecutive year
The seasoning maker raised its quarterly payout to $0.48 per share, payable Oct. 26, marking the 102nd straight year of dividend payments from the Hunt Valley-based company.
Scholastic Reports Wider Q1 FY2027 Loss, Affirms Guidance Amid Revenue Decline
The children’s publishing giant reported a $3.63 loss per share in Q1 FY2027, a 44% increase from the prior year, as revenue fell 4% to $216.8 million.
Rapid Micro Biosystems Seeks 50%+ Gross Margins by 2028
Company highlights early growth, recurring revenue and FDA-approved system adoption in pharma and advanced therapies
QuantumScape Shares Hit 52-Week Low as Q2 Losses Mount
Solid-state battery maker QuantumScape dropped to $4.76, marking a 61.7% decline over the past year, even as second-quarter adjusted EBITDA losses came in line with expectations.
Aon Stock Hits 52-Week Low Near $277.55 as Acquirer Weighs $17B USI Deal
Aon PLC shares touched a 52-week low near $277.55 amid a ~20% annual decline. The insurer is funding a roughly $17 billion acquisition of USI Advantage with a $13.4 billion senior-notes offering.
Octopus Investments trims stake in Everplay Group below 8% threshold
London-based Octopus Investments reduced its holding in Everplay Group to 7.99%, filing a major-shareholder notification with the LSE's Regulatory News Service.
Maximus Stock Falls to 52-Week Low as Profit Outlook Cut
Maximus Inc. hit a 52-week low of $52.72, down nearly half from its high, after adjusting its full-year profit outlook over a temporary pause in VA contract incentives.
Sempra Energy hits $19.43 low as 11.6% year-on-year drop continues
The utility’s shares fell to a five-year low amid broader market pressures and sector-specific challenges.
Aberdeen Intermediate Income Approves 1-for-6 Reverse Stock Split
The closed-end fund's board approved consolidating every six shares into one ahead of Oct. 8 trading, aiming to raise its per-share market price.
Aberdeen fund approves 1-for-5 reverse stock split
The Aberdeen Government Markets Income Fund said its board approved a 1-for-5 reverse split effective Oct. 8, aiming to raise its per-share price and broaden platform eligibility.